YungShin Global Holding Corporation (TPE:3705)
Taiwan · Delayed Price · Currency is TWD 56.70
+0.20 (0.35%)
Dec 3, 2025, 1:35 PM CST
YungShin Global Holding Revenue
YungShin Global Holding had revenue of 1.91B TWD in the quarter ending September 30, 2025, a decrease of -9.13%. This brings the company's revenue in the last twelve months to 8.37B, up 7.05% year-over-year. In the year 2024, YungShin Global Holding had annual revenue of 8.03B with 14.29% growth.
Revenue (ttm)
8.37B
Revenue Growth
+7.05%
P/S Ratio
1.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
15.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.03B | 1.00B | 14.29% |
| Dec 31, 2023 | 7.03B | -283.83M | -3.88% |
| Dec 31, 2022 | 7.31B | -493.29M | -6.32% |
| Dec 31, 2021 | 7.81B | -279.61M | -3.46% |
| Dec 31, 2020 | 8.08B | -106.87M | -1.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |